440 related articles for article (PubMed ID: 36323829)
21. [METTL3 inhibitor STM2457 improves metabolic dysfunction-associated fatty liver disease by regulating mitochondrial function in mice].
Gao Y; Wang P; Lu S; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1689-1696. PubMed ID: 37933644
[TBL] [Abstract][Full Text] [Related]
22. Network pharmacology-based identification of significant pathway for protection of Yinhuang granule in a mice model of metabolic-associated fatty liver disease.
Yan S; Zhang S; Du A; Miao H; Lu B; Huang Z; Ji L
Phytomedicine; 2021 Oct; 91():153666. PubMed ID: 34339944
[TBL] [Abstract][Full Text] [Related]
23. The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis.
Heida A; Gruben N; Catrysse L; Koehorst M; Koster M; Kloosterhuis NJ; Gerding A; Havinga R; Bloks VW; Bongiovanni L; Wolters JC; van Dijk T; van Loo G; de Bruin A; Kuipers F; Koonen DPY; van de Sluis B
Mol Metab; 2021 Dec; 54():101349. PubMed ID: 34626855
[TBL] [Abstract][Full Text] [Related]
24. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
25. Sodium sulfite triggered hepatic apoptosis, necroptosis, and pyroptosis by inducing mitochondrial damage in mice and AML-12 cells.
Liu M; Lu J; Hu J; Chen Y; Deng X; Wang J; Zhang S; Guo J; Li W; Guan S
J Hazard Mater; 2024 Apr; 467():133719. PubMed ID: 38335615
[TBL] [Abstract][Full Text] [Related]
26. Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway.
Gu Y; Duan S; Ding M; Zheng Q; Fan G; Li X; Li Y; Liu C; Sun R; Liu R
Phytomedicine; 2022 Aug; 103():154219. PubMed ID: 35691075
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
28. Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.
Zhao J; Hu Y; Peng J
Cell Mol Biol Lett; 2021 May; 26(1):17. PubMed ID: 33962586
[TBL] [Abstract][Full Text] [Related]
29. Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction-associated fatty liver disease.
Zheng K; Zhou W; Ji J; Xue Y; Liu Y; Li C; Zhang Z; Lu J; Shi X; Li Y
J Ethnopharmacol; 2023 Apr; 305():116081. PubMed ID: 36608777
[TBL] [Abstract][Full Text] [Related]
30. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.
Sun N; Shen C; Zhang L; Wu X; Yu Y; Yang X; Yang C; Zhong C; Gao Z; Miao W; Yang Z; Gao W; Hu L; Williams K; Liu C; Chang Y; Gao Y
Gut; 2021 Nov; 70(11):2183-2195. PubMed ID: 33257471
[TBL] [Abstract][Full Text] [Related]
31. Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway.
Guan Q; Wang Z; Hu K; Cao J; Dong Y; Chen Y
Int J Biol Sci; 2023; 19(12):3937-3950. PubMed ID: 37564204
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathway.
Chen L; Yu S; Hong S; Lin X; Zhu X; Cao X; Li Y; Xiao H
Drug Dev Res; 2023 Apr; 84(2):156-171. PubMed ID: 36541217
[TBL] [Abstract][Full Text] [Related]
33. Exploring the therapeutic potential of a nano micelle containing a carbon monoxide-releasing molecule for metabolic-associated fatty liver disease by modulating hypoxia-inducible factor-1α.
Cui Y; Guo C; Xia Z; Xue Y; Song B; Hu W; He X; Liang S; Wei Y; Zhang C; Wang H; Xu D; Zhang S; Fang J
Acta Biomater; 2023 Oct; 169():500-516. PubMed ID: 37574157
[TBL] [Abstract][Full Text] [Related]
34. Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity.
Li X; Wang TX; Huang X; Li Y; Sun T; Zang S; Guan KL; Xiong Y; Liu J; Yuan HX
Liver Int; 2020 Jun; 40(6):1378-1394. PubMed ID: 32145145
[TBL] [Abstract][Full Text] [Related]
35. The Gut Microbiome and Ferroptosis in MAFLD.
Ji J; Wu L; Wei J; Wu J; Guo C
J Clin Transl Hepatol; 2023 Feb; 11(1):174-187. PubMed ID: 36406312
[TBL] [Abstract][Full Text] [Related]
36. The natural flavone acacetin protects against high-fat diet-induced lipid accumulation in the liver via the endoplasmic reticulum stress/ferroptosis pathway.
Jiang Z; Sun H; Miao J; Sheng Q; Xu J; Gao Z; Zhang X; Song Y; Chen K
Biochem Biophys Res Commun; 2023 Jan; 640():183-191. PubMed ID: 36516527
[TBL] [Abstract][Full Text] [Related]
37. Silent information regulator sirtuin 1 ameliorates acute liver failure
Zhou XN; Zhang Q; Peng H; Qin YJ; Liu YH; Wang L; Cheng ML; Luo XH; Li H
World J Gastroenterol; 2024 Mar; 30(11):1588-1608. PubMed ID: 38617450
[TBL] [Abstract][Full Text] [Related]
38. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis.
Guo T; Yan W; Cui X; Liu N; Wei X; Sun Y; Fan K; Liu J; Zhu Y; Wang Z; Zhang Y; Chen L
Mol Med; 2023 Sep; 29(1):132. PubMed ID: 37770820
[TBL] [Abstract][Full Text] [Related]
39. A synthetic peptide AWRK6 ameliorates metabolic associated fatty liver disease: involvement of lipid and glucose homeostasis.
Jin L; Sun Y; Li Y; Zhang H; Yu W; Li Y; Xin Y; Alsareii SA; Wang Q; Zhang D
Peptides; 2021 Sep; 143():170597. PubMed ID: 34118361
[TBL] [Abstract][Full Text] [Related]
40. Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis.
Lan T; Geng XJ; Zhang SJ; Zeng XX; Ying JJ; Xu Y; Liu SY; Li P; Tong YH; Wang W; Mao ZJ; Wang SW
Phytomedicine; 2024 Jan; 123():155209. PubMed ID: 37984123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
